Citigroup’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.9M Buy
+2,044,900
New +$54.9M 0.02% 597
2026
Q1
Sell
-148,100
Closed -$4.81M 6133
2025
Q4
$4.81M Hold
148,100
﹤0.01% 2039
2025
Q3
$8.4M Sell
148,100
-18,000
-11% -$922K ﹤0.01% 1621
2025
Q2
$8.28M Buy
166,100
+106,100
+177% +$4.8M ﹤0.01% 1502
2025
Q1
$1.77M Buy
+60,000
New +$2.23M ﹤0.01% 2806
2024
Q4
Sell
-20,000
Closed -$368K 5886
2024
Q3
$368K Buy
+20,000
New +$358K ﹤0.01% 3923
2021
Q2
Sell
-30,000
Closed -$397K 6241
2021
Q1
$397K Buy
+30,000
New +$503K ﹤0.01% 3601

Other funds holding HIMS

Citigroup's HIMS Position: Q2 2026 in Review

Citigroup reduced its Hims & Hers Health (HIMS) stake by 66% in Q2 2026, selling an estimated $11.8M and leaving 222,301 shares worth $7.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Citigroup first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $15.4M in Q3 2025. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Citigroup held 222,301 shares of Hims & Hers Health worth $7.71M as of Q2 2026.
  • Citigroup sold 440,627 Hims & Hers Health shares in Q2 2026, an estimated $11.8M.
  • Hims & Hers Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1793 holding.
  • Citigroup first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Hims & Hers Health position peaked at $15.4M in Q3 2025.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.